Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Does not alter clinical vascular management in obesity; leaves open adipokine-targeted therapies for prospective trials.
Maenhaut et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: